July 7, 2022
Like many young people, Chase, 18, noticed she was developing symptoms of depression when the COVID-19 pandemic started.
Although she’d tried medications and therapy, Chase felt her symptoms get worse over the course of a few months. And she knew things were really getting serious when thoughts of suicide crept in.
That’s when her mother found research about a new type of treatment for depression called Stanford neuromodulation therapy, which uses magnetic fields to stimulate the brain. (It was previously referred to as Stanford accelerated intelligent neuromodulation therapy or SAINT.)
The treatment is similar to transcranial magnetic stimulation, a non-invasive therapy that’s been used to help treat depression for about 15 years.